Ministerio de Salud: Recomendaciones
- Nación:
https://www.boletinoficial.gob.ar/busquedaAvanzada/busquedaEspecial - Provincia de Buenos Aires:
https://normas.gba.gob.ar/covid-19
Organización Panamericana de la Salud (OPS) – Argentina / CDC
OPS: cursos sobre COVID-19 en español
OPS Recursos de información relacionados con el nuevo coronavirus
Vitrina del conocimiento: Nuevo coronavirus
CDC – Centros para el Control y la Prevención de Enfermedades – USA Recomendaciones, cómo protegerse
Sociedades científicas: Recursos
VACUNAS CONTRA LA COVID-19. Coadministración con otras vacunas
ALERTA DE LA RPVF 22/02/2021 Sinopharm
http://www.colfarma.info/colfarma/alerta-de-la-rpvf-22-02-2021-sinopharm/
ALERTA DE LA RPVF 18/02/2021 Vacuna Sputnik V: Nueva presentación del Componente 1
ALERTA DE LA RPVF 11/02/2021 SPUTNIK V: ACTUALIZACIÓN SOBRE SITUACIONES ESPECIALES EN LA POBLACIÓN OBJETIVO A VACUNAR
Sexto Informe de seguridad en vacunas. Vacunación COVID-19 en Argentina
https://bancos.salud.gob.ar/sites/default/files/2021-02/6to-informe-seguridad-en-vacunas-09_02.pdf
Lineamientos técnicos para la Campaña Nacional de Vacunación contra la COVID-19
Comunicación sobre datos preliminares de seguridad de vacunas que se están administrando en países de la Región. (20/01/21)
http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/01/ESP-Nota-seguridad-de-vacunas-I.pdf
Resumen inicial de ESAVIs reportados para vacunas que se están utilizando en países de la Región.(19/01/21)
Sputnik V: actualización de las condiciones para la conservación y uso de la vacuna
http://cime.fcq.unc.edu.ar/wp-content/uploads/sites/15/2021/02/Memo-SPUNTIK-V-3.2.2021.pdf
Evaluación del riesgo por contagio de coronavirus SARS-CoV-2 y medidas preventivas recomendadas en la prestación de servicios profesionales farmacéuticos asistenciales (SPFA)
AEMPS: 1º Informe de Farmacovigilancia sobre vacunas COVID-19 (25-01-2021)
Seguridad y eficacia preliminar de las vacunas para la prevención de COVID-19
http://www.evidencia.org/index.php/Evidencia/article/view/6912/4503
Autorización con carácter de emergencia: vacuna COVISHIELD/ ChAdOx1nCoV-19 Corona Virus Vaccine – Recombinant
https://www.boletinoficial.gob.ar/detalleAviso/primera/240575/20210209
VACUNAS CONTRA COVID-19
https://www.iecs.org.ar/wp-content/uploads/IECS-IRR-818-VA-Vacuna-covid-1.pdf
Recomendaciones para el USO CON FINES TERAPÉUTICOS DE INMUNOGLOBULINAS EQUINAS FRAGMENTOS F (ab´)2 ANTI SARS-CoV-2 EN COVID-19
Actualización ficha técnica RACIM de ivermectina (versión 3)
Novel Coronavirus 2019, Actualización 11-01-2021 – Representación OPS/OMS Argentina
COVID-19: INFORMACIÓN SOBRE PLATAFORMAS DE VACUNAS
Vacuna contra coronavirus: No está comprobado que todos Los pacientes que hayan tenido una reacción alérgica grave deban evitar la vacunación
Mitos y verdades sobre la vacunación COVID-19 en Argentina
Therapeutics and COVID‐19
COVID-19: Recomendaciones para calefacción, ventilación y aire acondicionado en establecimientos de salud
Ventilación y COVID-19 en la Industria
https://www.argentina.gob.ar/sites/default/files/ficha_tecnica_ventilacion_y_covid_150920.pdf
Infografía: Resistencia a los Antimicrobianos y COVID-19
https://www.paho.org/es/documentos/infografia-resistencia-antimicrobianos-covid-19
COVID-19: Acciones regulatorias de ANMAT
https://www.argentina.gob.ar/anmat/covid-19-acciones-regulatorias-de-anmat
PROTOCOLO DE ACTUACIÓN DESDE LAS FARMACIAS COMUNITARIAS
Impacto de los sistemas de ventilación en la transmisión del SARS–CoV–2. Recomendaciones generales para los edificios de uso público
Ivermectina para el tratamiento y/o profilaxis de COVID-19
Una actualización de la investigación de las vacunas contra COVID-19 y otras consideraciones como el monitoreo de eventos adversos, la transparencia y la calidad de la investigación clínica.
Draft landscape of COVID-19 candidate vaccines
https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
Global research on coronavirus disease (COVID-19)
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov
Materiales para equipos de salud – Ministerio de Salud de la Nación
http://www.msal.gob.ar/index.php/component/bes_contenidos/?filter_problematica=100&filter_soporte=0&start=60
COVID-19INTERACCIONES MEDICAMENTOSAS
https://www.argentina.gob.ar/sites/default/files/covid-19_interacciones-medicamentosas.pdf
Aspectos de Bioseguridad. Pandemia COVID-19 – SARS-CoV-2 Subcomisión de Bioseguridad y Biocustodia, Asociación Argentina de Microbiología
https://www.aam.org.ar/src/img_up/29032020.0.pdf
COVID-19 resúmenes de artículos en español. Sociedad Iberoamericana de Información Científica
https://www.siicsalud.com/
Repositorio COVID-19 (ITAES)
https://www.itaes.org.ar/RepositorioCOVID19.aspx?secId=81
Artículos científicos
Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine
Decontaminating N95 respirators during the COVID-19 pandemic: simple and practical approaches to increase decontamination capacity, speed, safety and ease of use
https://www.journalofhospitalinfection.com/article/S0195-6701(20)30570-3/pdf
Decontamination of common healthcare facility surfaces contaminated with SARS-CoV-2 using peracetic acid dry fogging
https://www.journalofhospitalinfection.com/article/S0195-6701(20)30581-8/pdf
Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study
https://www.bmj.com/content/bmj/372/bmj.n311.full.pdf
FLCC. Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
https://osf.io/wx3zn/?fbclid=IwAR0r7JRRaG4yQ08EiOrJFw2GA0Lkc2sL3eSTj9Bjkp_-BZYNi5saLVk8EAo
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30464-8/fulltext
Drug interactions for elderly with respiratory disorders and times of COVID-19: a systematic scoping review
https://revistas.udea.edu.co/index.php/vitae/article/view/343796/20804337
Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19
https://www.medrxiv.org/content/10.1101/2021.01.26.21250494v1
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”
https://www.repositoriosalud.es/bitstream/10668/3215/1/Entrenas_EffectOfCalcifediol.pdf
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Severe sinus bradycardia associated with Remdesivir in a child with severe SARS-CoV-2 infection
https://link.springer.com/article/10.1007/s00431-021-03940-4
From Hydroxychloroquine to Ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?
https://academic.oup.com/jtm/advance-article/doi/10.1093/jtm/taab005/6106246
Focus on COVID-19: Antiviral polymers in drugs and vaccines
https://www.polimery.umed.wroc.pl/pdf/2020/50/2/75.pdf
Quinacrine, an Antimalarial Drug with Strong Activity Inhibiting SARS-CoV-2 Viral Replication In Vitro
https://www.mdpi.com/1999-4915/13/1/121/pdf
Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection
https://www.researchsquare.com/article/rs-148845/v1
Excipients as potential agents of anaphylaxis in vaccines: analyzing the formulations of the current authorized COVID-19 vaccines
http://www.jiaci.org/revistas/doi10.18176_jiaci.0667.pdf
Allergic reactions to COVID-19 -vaccinations – unveiling the secret(s)
https://onlinelibrary.wiley.com/doi/epdf/10.1111/all.14734
La Quercetina como un potencial nutracéutico contra la enfermedad por coronavirus 2019 (COVID-19)
https://revistaseug.ugr.es/index.php/ars/article/view/15684/15561
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
https://science.sciencemag.org/content/early/2021/01/22/science.abf4058/tab-pdf
Potential beneficial role of probiotics on the outcome of COVID-19 patients: An evolving perspective
https://www.sciencedirect.com/science/article/pii/S187140212030535X?via%3Dihub
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
mRNA-1273 Study Group. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Safety and efficacy of the BNT162b2 Covid-19 vaccine
Manifestações Cutâneas Associadas à COVID-19: Uma Revisão Narrativa
https://actamedicaportuguesa.com/revista/index.php/amp/article/view/14574/6218
Clinical and Pathogenic Correlations Between SARS-CoV-2 Infection and Hemolytic Uremic Syndrome in Children
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726516/pdf/maedica-15-376.pdf
Administration of intravenous immunoglobulin in the treatment of COVID‐19: a review of available evidence
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26727
Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
https://www.sciencedirect.com/science/article/pii/S0169409X20302775?via%3Dihub
Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro
https://www.sciencedirect.com/science/article/pii/S0024320520316428?via%3Dihub
Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System
https://www.ackdjournal.org/article/S1548-5595(20)30112-9/fulltext
A systematic review of possible airborne transmission of the COVID-19 virus (SARS-CoV-2) in the indoor air environment
https://www.sciencedirect.com/science/article/pii/S0013935120315097?via%3Dihub
Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19?
https://www.maturitas.org/article/S0378-5122(20)30346-7/fulltext
Vitamin C—An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19
https://www.mdpi.com/2072-6643/12/12/3760/pdf
Vaccinating Pregnant and Lactating Patients Against COVID-19
Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19
https://jamanetwork.com/journals/jama/fullarticle/2773516
Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 Registry
https://www.tandfonline.com/doi/abs/10.1080/07853890.2020.1836566
Review of registered clinical trials for the treatment of COVID‐19
https://onlinelibrary.wiley.com/doi/10.1002/ddr.21762
Pre-hospitalization proton pump inhibitor use and clinical outcomes in COVID-19
Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications
https://www.tandfonline.com/doi/full/10.1080/17512433.2021.1856655
Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study
https://www.tandfonline.com/doi/full/10.1080/17476348.2021.1856659
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality
https://advances.sciencemag.org/content/early/2020/11/13/sciadv.abe4724.full
A Nursing Researcher’s Experience in a COVID-19 Vaccine Trial
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2773790
Ongoing Living Update of Potential COVID-19 Therapeutics: Summary of Rapid Systematic Reviews. Rapid Review
Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications
Reacciones adversas a fármacos utilizados en el tratamiento específico de la infección por SARS‐CoV‐2
Hospital Radiopharmacy in Argentina during the COVID‐19 pandemic. Criteria and rationale for the organization of work
https://www.sciencedirect.com/science/article/pii/S2253654X20301712?via%3Dihub
A Randomized Trial of Convalescent Plasma in Covid‐19 Severe Pneumonia
https://www.nejm.org/doi/full/10.1056/NEJMoa2031304?query=featured_home
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID‐19 patients: results from a randomized controlled clinical trial
https://erj.ersjournals.com/content/erj/early/2020/09/09/13993003.02808‐2020.full.pdf
Successful Treatment of a COVID‐19 Case with Pneumonia and Renal Injury Using Tocilizumab
https://www.mdpi.com/2571‐841X/3/4/29/htm
SARS‐CoV‐2 immunity: review and applications to phase 3 vaccine candidates
A pilot study on the preventative potential of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 transmission
https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/10817/9289
Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead
SARS-CoV-2 and inflammatory responses: from mechanisms to the potential therapeutic use of intravenous immunoglobulin
https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26651
COVID-19 et vaccination : une dérégulation globale
https://www.medecinesciences.org/en/articles/medsci/pdf/2020/10/msc200259.pdf
Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy
https://link.springer.com/article/10.1007/s40266-020-00812-8
Could ozone be an effective disinfection measure against the novel coronavirus (SARS-CoV-2)?
https://www.jpmh.org/index.php/jpmh/article/view/1596/776
Sitagliptin: a potential drug for the treatment of COVID-19?
https://hrcak.srce.hr/index.php?show=clanak&id_clanak_jezik=344935&lang=en
Safety and efficacy of Artemisinin-Piperaquine for treatment of COVID-19: an open-label, non-randomized, and controlled trial
https://www.sciencedirect.com/science/article/pii/S0924857920304271?via%3Dihub
Pharmacotherapy for Hospitalized Patients with COVID-19: Treatment Patterns by Disease Severity
https://link.springer.com/article/10.1007%2Fs40265-020-01424-7
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
https://science.sciencemag.org/content/sci/early/2020/11/05/science.abe1107.full.pdf
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2931866-3
Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply
https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2931970-X
Efficacy and safety of disinfectants for decontamination of N95 and SN95 filtering facepiece respirators: a systematic review
Microwave- and heat-based decontamination of N95 filtering facepiece respirators: a systematic review
The use of germicidal ultraviolet light, vaporized hydrogen peroxide and dry heat to decontaminate face masks and filtering respirators contaminated with a SARS-CoV-2 surrogate virus
Unintended consequences of long-sleeved gowns in a critical care setting during the COVID-19 pandemic
Laundering single-use gowns in the event of critical shortage: experience of a UK acute trust
Rapid SARS-CoV-2 inactivation by commonly available chemicals on inanimate surfaces
2019 Novel Coronavirus (COVID-19) Pandemic: BuiltEnvironment Considerations To Reduce Transmission
https://msystems.asm.org/content/msys/5/2/e00245-20.full.pdf
Association of SARS-CoV-2 Genomic Load with COVID-19 Patient Outcomes
https://www.atsjournals.org/doi/abs/10.1513/AnnalsATS.202008-931RL
The Potential Therapeutic Role of Proton Pump Inhibitors in COVID-19: Hypotheses Based on Existing Evidences
https://www.thieme-connect.de/products/ejournals/html/10.1055/a-1236-3041
Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239799
Natural compounds as inhibitors of SARS-CoV-2 endocytosis: A promising approach against COVID-19
https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/10520/9312
